John Vissing

Research interests

Publications

• OxPhos defects cause hypermetabolism and reduce lifespan in cells and in patients with mitochondrial diseases

  Communications Biology · 2023 · 10.1038/s42003-022-04303-x

• Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

  The Lancet Neurology · 2021 · https://doi.org/10.1016/s1474-4422(21)00159-9

• Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults

  JAMA Network Open · 2020 · 10.1001/jamanetworkopen.2020.20836

• Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis

  Neurology · 2020 · 10.1212/wnl.0000000000011108

• Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

  Journal of the Neurological Sciences · 2020 · 10.1016/j.jns.2020.116803

• Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis

  Muscle & Nerve · 2019 · 10.1002/mus.26447

• 229th ENMC international workshop: Limb girdle muscular dystrophies – Nomenclature and reformed classification Naarden, the Netherlands, 17–19 March 2017

  Neuromuscular Disorders · 2018 · https://doi.org/10.1016/j.nmd.2018.05.007

• Congenital Titinopathy: Comprehensive characterization and pathogenic insights

  Annals of Neurology · 2018 · 10.1002/ana.25241

• Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

  The Lancet Neurology · 2017 · https://doi.org/10.1016/s1474-4422(17)30369-1

• European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10‐year experience

  European Journal of Neurology · 2017 · 10.1111/ene.13285

• Quantitative Muscle MRI as an Assessment Tool for Monitoring Disease Progression in LGMD2I: A Multicentre Longitudinal Study

  PLoS ONE · 2013 · 10.1371/journal.pone.0070993

• Cardiac manifestations of myotonic dystrophy type 1

  International Journal of Cardiology · 2011 · 10.1016/j.ijcard.2011.08.037

• McArdle disease: a clinical review

  Journal of Neurology Neurosurgery & Psychiatry · 2010 · 10.1136/jnnp.2009.195040

• Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations

  Brain · 2007 · 10.1093/brain/awl383

• High prevalence and phenotype–genotype correlations of limb girdle muscular dystrophy type 2I in Denmark

  Annals of Neurology · 2006 · 10.1002/ana.20824

• Aerobic conditioning: An effective therapy in McArdle's disease

  Annals of Neurology · 2006 · 10.1002/ana.20881

• Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy

  Brain · 2006 · 10.1093/brain/awl149

• Aerobic training improves exercise performance in facioscapulohumeral muscular dystrophy

  Neurology · 2005 · 10.1212/01.wnl.0000150584.45055.27

• Recombination of Human Mitochondrial DNA

  Science · 2004 · https://doi.org/10.1126/science.1096342

• Novel POLG mutations in progressive external ophthalmoplegia mimicking mitochondrial neurogastrointestinal encephalomyopathy

  European Journal of Human Genetics · 2003 · 10.1038/sj.ejhg.5201002

• Identification and Characterization of a Common Set of Complex I Assembly Intermediates in Mitochondria from Patients with Complex I Deficiency

  Journal of Biological Chemistry · 2003 · 10.1074/jbc.m304998200

• The Effect of Oral Sucrose on Exercise Tolerance in Patients with McArdle's Disease

  New England Journal of Medicine · 2003 · 10.1056/nejmoa031836

• Spontaneous "Second Wind" and Glucose-Induced Second "Second Wind" in McArdle Disease

  Archives of Neurology · 2002 · 10.1001/archneur.59.9.1395

• Paternal Inheritance of Mitochondrial DNA

  New England Journal of Medicine · 2002 · https://doi.org/10.1056/nejmoa020350

• Exercise-Induced Changes in Local Cerebral Glucose Utilization in the Rat

  Journal of Cerebral Blood Flow & Metabolism · 1996 · 10.1097/00004647-199607000-00025

Current projects

No projects listed.